Yuan et al., when detecting BCL2 using 12 cell lines derived from human ovarian cancer cells, showed that the level of BCL2 expression was negatively correlated with cisplatin sensitivity [13]. This evidence concerns the gene BCL2 and ovarian carcinoma.